Display search results for ** instead (23 products)

Showing 1-10 of 23

30 Nov 2020  |  Global

Analysing Sepsis Management Part II: Treatments

Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics

Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

USD 4,950.00

USD 4,455.00 save 10 %

04 Dec 2020  |  Global

Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

USD 4,950.00

USD 4,455.00 save 10 %

09 Dec 2020  |  Global

Frost Radar™: Microbiome Therapeutics, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

USD 4,950.00
15 Dec 2020  |  Global

Frost Radar™: Advanced Antibodies, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations ...

USD 4,950.00
29 Oct 2020  |  Global

Frost Radar™:Transformative Influenza Vaccines, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

USD 4,950.00

USD 4,455.00 save 10 %

24 Dec 2020  |  Global

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...

USD 4,950.00
29 Apr 2020  |  Global

Technology Breakthroughs Driving Allergy & Infectious Disease Therapy

Forthcoming and Available Therapies for Allergy, Infectious Diseases and COVID-19

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...

USD 4,950.00

USD 4,207.50 save 15 %

12 May 2020  |  Global

Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring

Mobile-based Platforms, Artificial Intelligence-based Algorithms, and Video Analysis Defining New Approaches for Remote Patient Monitoring

Wearable devices such as smart watch and bands have gained huge acceptance from the healthcare industry as they can continuously track different health parameters and offers valuable insights to the healthcare providers anytime without any need for clinic visits. Even after huge market adoption of wearable devices, patients still complain about the...

USD 4,950.00

USD 4,207.50 save 15 %

24 Jun 2020  |  Global

Technological Advances Facilitating Research Across Preclinical Disease Models

Bioengineering Innovations in Preclinical Research

The key focus of this research has been outlined as below: 1. Technology benchmarking and roadmap, market trends, capabilities, and applications targeted: Build a robust strategy by defining the universe of preclinical disease models opportunities and setting key priorities 2. Stakeholder activities, influence, industry initiatives: Evaluate opport...

USD 4,950.00

USD 4,455.00 save 10 %

22 Apr 2020  |  Global

Fuelling Digital Pathology Advances Using Artificial Intelligence

Leveraging the Interplay between Leading Edge Computing and Digital Imaging Solutions toward Precision Medicine

The astonishing progress of combinatorial chemistry, the development of high throughput screening techniques, parallel computing, and quantum mechanics modeling approaches, among many other cutting-edge innovations, has derived in a Big Data explosion. In parallel, the advent of structural biology, the omics revolution, and the extraordinary progr...

USD 4,950.00

USD 4,207.50 save 15 %

Showing 1-10 of 23